ALADDIN: An integrated tool for computer-assisted molecular design and pharmacophore recognition from geometric, steric, and substructure searching of three-dimensional molecular structures
暂无分享,去创建一个
[1] Johnz Willett. Similarity and Clustering in Chemical Information Systems , 1987 .
[2] I. Kuntz,et al. Docking flexible ligands to macromolecular receptors by molecular shape. , 1986, Journal of medicinal chemistry.
[3] J M Blaney,et al. A geometric approach to macromolecule-ligand interactions. , 1982, Journal of molecular biology.
[4] David Bawden,et al. Pharmacophoric pattern matching in files of 3d chemical structures: evaluation of search performance , 1987 .
[5] Michael Jan. Williams,et al. Receptor pharmacology and function , 1989 .
[6] Ralph E. Christoffersen,et al. Computer-assisted drug design , 1979 .
[7] H. Rollema,et al. Resolution of 5,6-dihydroxy-2-(N,N-di-n-propylamino)tetralin in relation to the structural and stereochemical requirements for centrally acting dopamine agonists. , 1985, Journal of medicinal chemistry.
[8] P. Willett,et al. Pharmacophoric pattern matching in files of 3d chemical structures: comparison of geometric searching algorithms , 1987 .
[9] Peter Willett,et al. Pharmacophoric pattern matching in files of 3-D chemical structures: election of interatomic distance screens , 1986 .
[10] P. Gund,et al. Three-dimensional molecular modeling and drug design. , 1980, Science.
[11] Momany Fa,et al. Conformational energy analysis of the molecule, luteinizing hormone-releasing hormone. I. Native decapeptide. , 1976 .
[12] Mark Powell,et al. Further examples of preferred transition state geometries in the oxidative cyclisation of indole and isoquinoline derivatives , 1981 .
[13] Garland R. Marshall,et al. Chapter 28. Pharmacophore Identification and Receptor Mapping , 1980 .
[14] J G Cannon,et al. Dopamine agonists: structure-activity relationships. , 1985, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.
[15] Eric T. Sun,et al. Amino acids derivatives that stabilize secondary structures of polypeptides , 1982 .
[16] Andrew T. Brint,et al. Identifying 3D maximal common substructures using Transputer networks , 1988 .
[17] J. Nilsson,et al. Dopamine D2 receptor binding sites for agonists. A tetrahedral model. , 1985, Molecular pharmacology.
[18] I. Kuntz,et al. Using shape complementarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure. , 1988, Journal of medicinal chemistry.
[19] P J Goodford,et al. Drug design by the method of receptor fit. , 1984, Journal of medicinal chemistry.
[20] R. Cramer,et al. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.
[21] P. Goodford. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.
[22] Yvonne C. Martin,et al. MENTHOR, a database system for the storage and retrieval of three-dimensional molecular structures and associated data searchable by substructural, biologic, physical, or geometric properties , 1988, J. Comput. Aided Mol. Des..
[23] Peter Willett,et al. Algorithms for the identification of three-dimensional maximal common substructures , 1987, J. Chem. Inf. Comput. Sci..
[24] B L Currie,et al. A new approach to conformationally restricted peptide analogs: rigid beta-bends. 1. Enkephalin as an example. , 1982, Biochemical and biophysical research communications.
[25] R Langridge,et al. Real-time color graphics in studies of molecular interactions. , 1981, Science.
[26] J. Bolin,et al. Crystal structures of Escherichia coli and Lactobacillus casei dihydrofolate reductase refined at 1.7 A resolution. I. General features and binding of methotrexate. , 1982, The Journal of biological chemistry.
[27] Garland R. Marshall,et al. The Conformational Parameter in Drug Design: The Active Analog Approach , 1979 .